Abstract

Meeting abstracts from the 64th British Thyroid Association Annual Meeting

Highlights

  • Suboptimal thyroid function in pregnancy is associated with adverse obstetric outcomes but it is unclear whether levothyroxine treatment, initiated during pregnancy is beneficial

  • In the present study we investigated the association of PTTG and pituitary tumor-transforming gene-binding factor (PBF) with p53-related genes in the TCGA thyroid cancer dataset, as well as in a bi-transgenic murine model (Bi-Tg) overexpressing PTTG and PBF in the thyroid gland

  • Characterisation of primary murine Bi-Tg thyrocytes revealed that coexpression of PTTG and PBF caused extensive repression of DNA-damage repair (DDR) genes (39/82 genes; P < 0.05)

Read more

Summary

Introduction

Suboptimal thyroid function in pregnancy is associated with adverse obstetric outcomes but it is unclear whether levothyroxine treatment, initiated during pregnancy is beneficial. Results In MCF-7 and MDA-MB-231 breast cancer cells with either exogenous or all-trans retinoic acid/dexamethasone-induced NIS expression, PBF significantly repressed radioiodine uptake and this was reversible with PP1 treatment. Conclusions TRAb is commonly used regionally with good sensitivity and specificity We propose that it should be added on by biochemistry labs in all newly thyrotoxic patients, as this could expedite diagnosis, minimising use of inappropriate antithyroid medications. The thyroxine absorption test is an established test to investigate the cause of persistently raised TSH in patients on levothyroxine. Method Patients with persistently raised TSH despite adequate thyroxine dose and admitting good compliance were offered the test. They were advised to fast and bring their own medication.

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call